• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Angi Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    4/1/25 5:13:14 PM ET
    $ANGIV
    Advertising
    Consumer Discretionary
    Get the next $ANGIV alert in real time by email
    false 0001705110 0001705110 2025-03-31 2025-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): March 31, 2025

     

    Angi Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-38220   82-1204801
    (State or other jurisdiction
    of incorporation)
      (Commission
    File No.)
      (I.R.S. Employer
    Identification No.)

     

    3601 Walnut Street, Suite 700, Denver, CO

      80205
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (303) 963-7200

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    (Title of each class) (Trading
    Symbol(s))
    (Name of each exchange on which
    registered)
    Class A Common Stock, par value $0.001 ANGI

    The Nasdaq Stock Market LLC

    (Nasdaq Global Select Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 3.02. Unregistered Sales of Equity Securities.

     

    On March 31, 2025, IAC Inc. (“IAC”) completed the previously announced spin-off of Angi Inc. (“Angi”) by means of a special dividend (the “Distribution”) of all of the shares of Angi capital stock held by IAC to the holders of IAC common stock, par value $0.0001 per share, and IAC Class B common stock, par value $0.0001 per share. On March 31, 2025, prior to the effective time of the Distribution, IAC voluntarily converted an aggregate of 41,701,064 shares of Angi Class B common stock, par value $0.001 per share (the “Angi Class B common stock”), that it owned into shares of Angi Class A common stock, par value $0.001 per share (the “Angi Class A common stock”), on a one-for-one basis, in accordance with the terms of the Angi Class B common stock (the “Conversion”). Angi did not receive any consideration in connection with the Conversion. The issuance by Angi of such 41,701,064 shares of Angi Class A common stock upon the Conversion was made in reliance upon the exemption from registration contained in Section 4(2) of the Securities Act of 1933, as amended.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      ANGI INC.
       
      By: /s/ Shannon M. Shaw
      Name: Shannon M. Shaw
      Title: Chief Legal Officer

     

    Date: April 1, 2025

     

     

     

    Get the next $ANGIV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANGIV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ANGIV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Boon Kris claimed ownership of 10,183 shares (SEC Form 3)

    3 - Angi Inc. (0001705110) (Issuer)

    4/10/25 4:38:06 PM ET
    $ANGIV
    Advertising
    Consumer Discretionary

    Chief Legal Officer Shaw Shannon converted options into 10,775 shares and covered exercise/tax liability with 3,165 shares, increasing direct ownership by 17% to 53,089 units (SEC Form 4)

    4 - Angi Inc. (0001705110) (Issuer)

    4/2/25 7:41:12 PM ET
    $ANGIV
    Advertising
    Consumer Discretionary

    $ANGIV
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Angi Inc.

    SCHEDULE 13D - Angi Inc. (0001705110) (Subject)

    4/3/25 7:00:29 AM ET
    $ANGIV
    Advertising
    Consumer Discretionary

    Angi Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Angi Inc. (0001705110) (Filer)

    4/1/25 5:13:14 PM ET
    $ANGIV
    Advertising
    Consumer Discretionary

    Angi Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Angi Inc. (0001705110) (Filer)

    4/1/25 8:50:39 AM ET
    $ANGIV
    Advertising
    Consumer Discretionary